CD4 and infection: In the recently reported Reduction of EArly mortaLITY in HIV-infected adults and children starting ART (REALITY) randomized trial, a broad enhanced anti-infection prophylaxis bundle reduced all-cause mortality vs cotrimoxazole alone in adults and children aged ≥5 years initiating ART with a CD4 count <100 cells/μL [6].